Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Table S3. from Raludotatug Deruxtecan, a CDH6-Targeting Antibody–Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer Models
  1. Home
  2. Publications
  3. Table S3. from Raludotatug Deruxtecan, a CDH6-Targeting Antibody–Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer Models

Table S3. from Raludotatug Deruxtecan, a CDH6-Targeting Antibody–Drug Conjugate with a DNA Topoisomerase I Inhibitor DXd, Is Efficacious in Human Ovarian and Kidney Cancer Models

Authors:
  • HSHirokazu Suzuki
    Hirokazu Suzuki
  • SNShotaro Nagase
    Shotaro Nagase
  • CSChiemi Saito
    Chiemi Saito
  • ATAtsuko Takatsuka
    Atsuko Takatsuka
  • MNMotoko Nagata
    Motoko Nagata
  • KHKokichi Honda
    Kokichi Honda
  • YKYuki Kaneda
    Yuki Kaneda
  • YNYumi Nishiya
    Yumi Nishiya
  • THTomoyo Honda
    Tomoyo Honda
  • TITomomichi Ishizaka
    Tomomichi Ishizaka
  • KNKensuke Nakamura
    Kensuke Nakamura
  • TNTakashi Nakada
    Takashi Nakada

Open Access
Publisher website
Google Scholar
  • 4 March 2024
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/1535-7163.25338007
Abstract
Concentration of sCDH6 in cell culture supernatant.
Keywords
  • DRUG TARGETS
  • CELL SURFACE RECEPTOR DRUG TARGETS
  • GENITOURINARY CANCERS
  • RENAL CANCER
  • GYNECOLOGICAL CANCERS
  • OVARIAN CANCER
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.